resources

2 Month Fellowship

2 Month Fellowship

Over the last 2 years, we have had several publications detailing the mission of the 300 in 10 initiative.  This ABS initiative is gaining national recognition and was referenced in the Journal of Nature.  As  you are aware, the goal is to train 30 competent brachytherapy teams per year over the next 10 years.  Prior to COVID, we were well on our way to training these teams from the ABS prostate workshops where we trained 130 teams in prostate HDR and LDR brachytherapy. From these workshops, about 80% of these teams have implemented prostate brachytherapy within 6 months of the school.  Training competent gynecologic brachytherapists is an equally high priority, as well as for other disease sites. We previously submitted 2 grants to fund the entire initiative, including the AMA and ROI (Radiation Oncology Institute); unfortunately, these were not funded.  While developing brachytherapy educational curriculum is important and will continue, the 2-month senior electives we have arranged at 22 institutions is one of the most important pillars of 300 in 10.  Unfortunately, due to COVID, these institutions cannot take a resident until the summer or fall of 2021 - based upon institutional travel restrictions.  Therefore, PGY 5 residents may need to look at other options after completing their residencies if additional brachytherapy training is needed.   The ABS BOD is working on various training opportunities.   Once we have clearance from these institutions, we will post the application process on our website. In the meantime, ABS has several ongoing virtual opportunities including virtual reality training videos, webinars, virtual outreach events (VOE), NexGenBrachytherapy, and a recent partnership with Grand Rounds in Urology to educate brachytherapists, other medical specialists, and the general public on the value of our specialty.  Thank you for your patience and for your support of 300 in 10 and other critical ABS strategic initiatives.  Our goal is to help you deliver the highest quality brachytherapy for your patients.


Firas Mourtada, PhD
ABS President


Daniel G Petereit, MD, FASTRO
ABS Chair of the board